Health Care

HHS Proposes Changes to the HIPAA Privacy Rule to Strengthen Privacy Protections for Reproductive Health Care Information (April 25, 2023)
DOJ’s Withdrawal of Policy Statements Relating to Antitrust Enforcement in Healthcare Markets (April 6, 2023)
In Bloomberg Law, Margaux Hall Discusses Drugmaker Data Protection in Medicare Price Negotiation Guidance (March 20, 2023)
In Bloomberg Law, Margaux Hall Discusses Legal Risks for Medicare as Drug Pricing Negotiation Deadlines Approach (February 23, 2023)
The U.S. Government Accountability Office Recommends Actions to Improve Federal Oversight of Institutional Review Boards for Human Research (February 17, 2023)
Mark Barnes Comments in Bloomberg Law on New Clinical Trial Diversity Requirements (February 6, 2023)
In Law360, Health Care Attorneys Analyze Clinical Trial Law Promoting Diversity (January 25, 2023)
Margaux Hall Presents at Medicaid & Government Pricing Congress (January 20, 2023)
The Centers for Medicare & Medicaid Services Proposes Changes to the Medicare Advantage and Medicare Part D Programs (January 18, 2023)
In Law360, Margaux Hall Offers Predictions for the 2023 Drug Pricing Landscape (January 17, 2023)
Congress Enacts Legislation Requiring Guidance on Clinical Research Diversity and Modernization (January 9, 2023)
In Law360, Health Care Attorneys Analyze Online Tracking Technology Regulatory & Compliance Issues Impacting Hospitals and Health Systems (December 23, 2022)
In an American Health Law Association Article, Attorneys Explore Value-Based Care Approach to Cancer Treatment (December 19, 2022)
David Peloquin Presents at U.S. Africa Leaders Summit Science Collaboration (December 16, 2022)
Medicare Rules: Promoting Competition? (November 15, 2022)
In Axios, David Ault Examines Biden Administration Plans to Reduce Drug Costs (October 24, 2022)
Deborah Gersh and Harvey Cotton Present Webinar on Dobbs Case Abortion Privacy Provisions (September 28, 2022)
In Healthcare Risk Management, Deborah Gersh Examines Hospital Emergency Department Legal Issues After SCOTUS Abortion Ruling (September 8, 2022)
In Law360, Health Care Attorneys Analyze How Enactment of the Inflation Reduction Act Paves the Way for Drug Pricing Reforms (September 1, 2022)
Congress Paves the Way for Drug Pricing Reforms with Passage of the Inflation Reduction Act of 2022 (August 12, 2022)
In Law360, Health Care Attorneys Co-Author Article on Privacy Guidance Related to Reproductive Health (August 2, 2022)
In Bloomberg Law, David Peloquin Discusses Privacy Protections Related to Reproductive Research (July 19, 2022)
In Law360, Health Care Attorneys Analyze HHS Medicare Drug Reimbursement (July 8, 2022)
In Modern Healthcare, Margaux Hall Discusses FTC Investigation of Pharmacy Benefit Managers (June 16, 2022)
In Technology Transfer Tactics Health Care Attorneys Analyze HHS Opinion Clarifying Anti-Kickback Rules for Physician Inventors (May 19, 2022)
In Law360, Attorneys Examine CMS Changes Coming to Medicare Part D Market (May 18, 2022)
D.C. Federal District Court Rules in Favor of Sentara Hospitals in Medicare Bad Debt Payment Case (April 1, 2022)
In Modern Healthcare, Margaux Hall Examines CMS Proposal for Medicare Part D Drugs (March 11, 2022)
DOJ Increases Focus on Clinical Trial Fraud (February 1, 2022)
On HIMSS-TV, Christine Moundas Analyzes Digital Health 2021 Highlights and 2022 Outlook (January 5, 2022)
In Law360, Attorneys Analyze DOJ Civil Cyber-Fraud Initiative Impact on Health Care Companies (December 22, 2021)
A New Year for Drug Pricing and Price Reporting? What’s Happening Now and What’s New for 2022 (December 14, 2021)
HHS Reverses Course on LDTs: COVID-19 LDTs Again Require FDA Premarket Review (December 3, 2021)
CMS Finalizes Repeal of Medicare “Breakthrough” Device Coverage Rule, Pledges to Invite Further Industry Input (November, 24, 2021)
DOJ Civil Cyber-Fraud Initiative May Impact Health Care and Life Sciences Companies (November 10, 2021)
Interim Final Rule Implements Controversial Surprise Billing Arbitration Provisions (October 14, 2021)
In Law360, Attorneys Analyze Takeaways from D.C. Circuit Medicare Advantage Overpayment Ruling (October 13, 2021)
In New York Magazine’s The Cut, Mark Barnes Discusses the Biden Administration’s COVID-19 Vaccine Mandate for Workers (October 1, 2021)
Margaux Hall to Present at Managed Markets & Account Management Strategies Conference (November 9, 2021)
Margaux Hall and Alison Fethke to Present at PLI Webcast on Drug Pricing Evolving Legal and Policy Landscape (September 20, 2021)
In Barron’s and USA Today, Mark Barnes Examines Whether President Biden’s New Vaccine Mandate Can Withstand Legal Challenges (September 13, 2021)
Proposed Rule on CY 2022 Physician Fee Schedule Addresses Telehealth (Especially Mental Health), Drug Pricing and Reimbursement, Provider Enrollment, Vaccines, and Physician-Owned Distributor Transparency (August 13, 2021)
Updated: Developments in Drug Pricing and Price Reporting as the Congressional Recess Approaches (August 2021) (August 11, 2021)
Developments in Drug Pricing and Price Reporting as the Congressional Recess Approaches (August 2021) (August 3, 2021)
Podcast: Non-binding Guidance: COVID-19 Vaccine Mandate Litigation (July 29, 2021)
In Law360, Health Care Attorneys Examine Compliance Considerations for Pharmaceutical Testing Programs (June 7, 2021)
Margaux Hall and Alison Fethke to Present at PLI Webcast on Drug Pricing Evolving Legal and Policy Landscape (September 20, 2021)
Mark Barnes Examines Subject-Sponsor Interactions in Report on Research Compliance (June 1, 2021)
Health Care Attorneys Analyze the Future of Telehealth (May 11, 2021)
Capital Clubhouse Named Finalist in DC Congresswoman Eleanor Holmes Norton’s Community Project Funding Initiative (April 28, 2021)
In Bloomberg Law, Attorneys Analyze Potential Costs of Reshoring Pharmaceutical Manufacturing (April 9, 2021)
Event: Navigating Life Sciences M&A Under the Biden Administration | Drug Pricing & Antitrust Considerations (March 25, 2021)
What the U.S. Federal Government Might Learn from States About Regulating Drug Pricing (March 24, 2021)
Podcast: CMMI Program Delays and Suspensions—Recommended Next Steps (March 18, 2021)
Law360 Profiles Tara Fisher on Guiding Novavax in Pursuit of COVID-19 Vaccine (March 11, 2021)
In Law360, Health Care Attorneys Analyze Information Blocking Rule Opportunities for Clinical Research (March 9, 2021)
Event: Outlook 2021 – Washington, D.C. Updates and Insights on Life Sciences and Health Care (February 25, 2021)
In Law360, Margaux Hall Examines Drug Commercialization and Market Access Strategies in Light of Drug Pricing Regulatory Uncertainty Under the Biden Administration (February 16, 2021)
2022 Medicare Advantage and Part D Final Rule Includes Update to Star Ratings System and Implementing Coverage and Transparency Measures (February 5, 2021)
Medicare Expands Coverage of “Breakthrough” Medical Devices and Codifies “Reasonable and Necessary” Standard (January 21, 2021)
Health Care Co-Chairs Address Key Issues Facing Health Payers in 2021 (January 8, 2021)
In Law360, Tom Bulleit Analyzes 2021 Health Policies Under the Biden Administration (January 5, 2021)
In Law360, Attorneys Evaluate 2021 IPO Market (January 5, 2021)
The 2020 Election and Health Care (December 15, 2020)
In Bloomberg Law, Tom Bulleit Discusses New “Stark” and Anti-Kickback Rules for Value-Based Arrangements (November 25, 2020)
In Law360, Health Care Attorneys Examine State Drug Pricing Reforms (November 25, 2020)

Cookie Settings